Holen Sie sich die Stockscreener-App
12.71
2.27%
-0.28
Schlusskurs vom Vortag:
$12.99
Offen:
$13
24-Stunden-Volumen:
1.03M
Relative Volume:
0.65
Marktkapitalisierung:
$597.10M
Einnahmen:
$217.11M
Nettoeinkommen (Verlust:
$-651.19M
KGV:
-0.9784
EPS:
-12.99
Netto-Cashflow:
$-387.26M
1W Leistung:
-5.19%
1M Leistung:
-21.34%
6M Leistung:
+80.33%
1J Leistung:
+63.81%
1-Tages-Spanne:
$12.46
$13.08
1-Wochen-Bereich:
$11.83
$13.38
52-Wochen-Spanne:
$5.00
$17.58
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Firmenname
Ginkgo Bioworks Holdings Inc
Sektor
Branche
Telefon
(877) 442-5362
Adresse
27 DRYDOCK AVENUE, BOSTON
Vergleichen Sie DNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
12.68 | 769.00M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.18 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.37 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
433.51 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
825.40 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.32 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-15 | Herabstufung | BTIG Research | Neutral → Sell |
| 2024-05-10 | Herabstufung | William Blair | Mkt Perform → Underperform |
| 2023-11-14 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2023-11-09 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-06-02 | Herabstufung | Goldman | Neutral → Sell |
| 2023-05-11 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2022-11-29 | Eingeleitet | Berenberg | Buy |
| 2022-10-04 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-03-02 | Fortgesetzt | Cowen | Outperform |
| 2022-02-23 | Eingeleitet | Goldman | Neutral |
| 2022-02-01 | Eingeleitet | BofA Securities | Neutral |
| 2022-01-28 | Eingeleitet | BofA Securities | Buy |
| 2022-01-07 | Eingeleitet | BTIG Research | Buy |
| 2021-11-29 | Eingeleitet | Jefferies | Buy |
| 2021-10-13 | Eingeleitet | Raymond James | Outperform |
| 2021-10-12 | Eingeleitet | William Blair | Outperform |
| 2021-09-20 | Eingeleitet | HSBC Securities | Buy |
Alle ansehen
Ginkgo Bioworks Holdings Inc Aktie (DNA) Neueste Nachrichten
Ginkgo Bioworks Wins Project Agreement Through BARDA's BioMaP-Cons Consortium - MarketScreener
Real time pattern detection on Ginkgo Bioworks Holdings Inc. stockWeekly Market Report & AI Enhanced Trade Execution Alerts - newser.com
Ginkgo Bioworks Holdings Inc. stock daily chart insightsWeekly Trade Review & Real-Time Volume Analysis - newser.com
Will Ginkgo Bioworks Holdings Inc. stock gain from lower inflationMarket Volume Report & Weekly High Momentum Picks - newser.com
Is it time to cut losses on Ginkgo Bioworks Holdings Inc.Profit Target & Free Growth Oriented Trading Recommendations - newser.com
Ginkgo Bioworks Awarded Project Agreement through BARDA's BioMaP-Consortium - PR Newswire
Ginkgo Bioworks and Bayer Extend Multi-Year Strategic Partnership to Accelerate Next Generation Biological Solutions for Agriculture - MarketScreener
Can Ginkgo Bioworks Holdings Inc. stock beat market expectations this quarterWeekly Trend Report & Daily Chart Pattern Signals - newser.com
How interest rate cuts could boost Ginkgo Bioworks Holdings Inc. stockShare Buyback & Free Verified High Yield Trade Plans - newser.com
Can Ginkgo Bioworks Holdings Inc. Class stock resist broad market declinesJuly 2025 Analyst Calls & Community Verified Watchlist Alerts - newser.com
Live market analysis of Ginkgo Bioworks Holdings Inc.2025 Stock Rankings & Safe Entry Trade Reports - newser.com
Visual trend scoring systems applied to Ginkgo Bioworks Holdings Inc.Portfolio Performance Report & Daily Volume Surge Trade Alerts - newser.com
Is Ginkgo Bioworks Holdings Inc. stock dividend yield sustainableQuarterly Trade Review & High Win Rate Trade Tips - newser.com
Is Ginkgo Bioworks Holdings Inc. Class stock a defensive play amid uncertaintyWeekly Trade Analysis & Low Volatility Stock Recommendations - newser.com
Statistical indicators supporting Ginkgo Bioworks Holdings Inc.’s strengthBear Alert & Verified Swing Trading Watchlists - newser.com
Ginkgo Bioworks (DNA) Expected to Announce Earnings on Thursday - MarketBeat
Why Ginkgo Bioworks Holdings Inc. Class stock fits value portfoliosSwing Trade & Safe Investment Capital Preservation Plans - newser.com
Ginkgo Bioworks Holdings, Inc. (DNA) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Ginkgo Bioworks Announces Date of First Quarter 2024 Results Pre - GuruFocus
Ginkgo Bioworks (NYSE:DNA) Shares Up 9.2%Here's What Happened - MarketBeat
Using Python tools to backtest Ginkgo Bioworks Holdings Inc. strategiesInsider Selling & Low Risk High Win Rate Stock Picks - newser.com
Will Ginkgo Bioworks Holdings Inc. Class stock announce a stock split2025 Volatility Report & Safe Capital Growth Plans - newser.com
Ginkgo Bioworks stock surges after extending Bayer partnership By Investing.com - Investing.com Canada
Ginkgo Bioworks, Bayer extend partnership for agricultural biologicals By Investing.com - Investing.com Canada
Will Ginkgo Bioworks Holdings Inc. continue its uptrendWeekly Earnings Recap & Low Drawdown Momentum Ideas - newser.com
Ginkgo Bioworks (NYSE: DNA) extends Bayer alliance to develop microbial nitrogen fixation - Stock Titan
How sentiment analysis helps forecast Ginkgo Bioworks Holdings Inc.July 2025 Fed Impact & Consistent Profit Focused Trading Strategies - newser.com
Is Ginkgo Bioworks Holdings Inc. stock oversold or undervaluedEarnings Growth Summary & Entry and Exit Point Strategies - newser.com
Published on: 2025-10-31 02:21:27 - newser.com
Can Ginkgo Bioworks Holdings Inc. stock surprise with earnings upside2025 Top Decliners & Long-Term Safe Investment Plans - newser.com
Finanzdaten der Ginkgo Bioworks Holdings Inc-Aktie (DNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.29%
0.16%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):